Stay updated on Lenvatinib and Pembrolizumab in DTC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in DTC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Two screenshots show only minor layout and timestamp differences. No substantive content changes to core study details (objectives, eligibility criteria, or outcomes) are visible.
    Difference
    0.3%
    Check dated 2025-11-03T20:50:53.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    30 days ago
    Change Detected
    Summary
    Summary of changes: Deleted the GI/RDI Genetic and Rare Diseases resource for Differentiated thyroid carcinoma and added a government-operating-status notice with a v3.2.0 update.
    Difference
    2%
    Check dated 2025-10-06T04:50:13.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T02:54:46.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2; the 'Back to Top' control was removed. No other core content, pricing, or availability changes were detected.
    Difference
    0.1%
    Check dated 2025-09-14T18:53:35.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, v3.0.1, indicating a recent revision. The previous version, v3.0.0, has been removed from the page.
    Difference
    0.2%
    Check dated 2025-09-07T14:08:09.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility and location information, as well as specific details about differentiated thyroid carcinoma and associated treatments, while removing outdated location and medical topic references.
    Difference
    4%
    Check dated 2025-08-31T11:41:02.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.